On September 22, 2023, a grand event of cell and gene ** was held in Shanghai.
The event was co-sponsored by Tongji Hospital Affiliated to Tongji University, School of Basic Medical Sciences of Naval Medical University, Shanghai Biomedical Industry Promotion Center, Biovalley and Mace Medicine, and was named "2023 (14th) Cell and Gene Symposium and Antibody Engineering and Innovative Immunity Technology Forum". The conference aims to promote innovation and collaboration in the field of medicine by promoting the latest research advances in the fields of cells and genes, antibody engineering and immunology.
The event attracted experts, scholars and business representatives from all over the country. Yongbao Health was invited to attend, and Wang Xiao, general manager of Yongbao Health Shenzhen Branch, and others attended the meeting on behalf of the company.
With the theme of translational medicine, the conference fully combines basic research and clinical application, and sets up a main forum and eight sub-forums. These sub-forums cover many fields such as clinical frontier research, clinical supervision, standardization, cell safety, new immune cells, solid tumors, stem cells and cancer, antibody drugs, nucleic acid drugs, gene editing, tumor immunity, etc., providing participants with opportunities for in-depth discussions.
Domestic and foreign experts from industry, academia, research and medicine gathered together to share their research results and experience, and the latest technologies and applications in these fields. These discussions sparked a collision of ideas and drove further innovation in related fields.
This forum not only provides a platform for experts and scholars in the field of cell and gene at home and abroad to communicate and learn, but also injects new impetus into the rapid development and industrialization of this field.
During the forum, many eye-catching technologies and application cases were presentedIncluding the latest technologies and products in the fields of cells and genes**, antibody engineering and immunology**. Innovative approaches such as novel gene editing technologies, CAR-T cells**, and immune checkpoint inhibitors also demonstrated the promise and potential of these fields to attendees. Forever Health is also with all the expertsIt also showcased our latest R&D products and solutions, and carried out academic exchanges and industrial cooperation with everyone.
The successful holding of this forum not only strengthened the exchanges and cooperation in the field of cell and gene technology at home and abroad, but also provided a strong impetus for promoting the development of this field. We look forward to this event continuing to contribute more wisdom and strength to future research and industrial development.